Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT
NCT07634393Phase 4Not yet recruiting
- Sponsor
- Montefiore Medical Center
- Start
- Oct 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of metoclopramide in Post-concussion syndrome (PCS) (2 arms), sponsored by Montefiore Medical Center. Primary endpoint: Rivermead Post-Concussion Symptoms Questionnaire score at 48 hours. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
metoclopramide
03
Conditions
Post-concussion syndrome (PCS)
Beyond the preview
Go deeper on NCT07634393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07634393.